Vimarsana
Biggest News Aggregation in the World

Page 24 - Cochlear Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cochlear Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cochlear Ltd Today - Breaking & Trending Today

Fort Myers-based NeoGenomics hires industry veteran Chris Smith as new CEO - Vimarsana News

Fort Myers-based NeoGenomics hires industry veteran Chris Smith as new CEO

Fort Myers-based NeoGenomics has appointed a new CEO after a months-long search.

Global Active Implantable Medical Devices Market Research Report to 2027 - Featuring 3M, Allergan, D - Vimarsana News

Global Active Implantable Medical Devices Market Research Report to 2027 - Featuring 3M, Allergan, D

DUBLIN--(BUSINESS WIRE)--The "Active Implantable Medical Devices Market Research Report by Product, End-User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.The Global Active Implantable Medical Devices Market size was estimated at USD 2,0...

Hearing Implant Market Is Projected to Grow at A Robust CAGR Of 7.31% Between 2021 And 2031 - Vimarsana News

Hearing Implant Market Is Projected to Grow at A Robust CAGR Of 7.31% Between 2021 And 2031

Surge in cases of hearing disability among the children and elderly population across the globe is a major factor fuelling growth.Future Market Insights (FMI) has projected the hearing implants market to register impressive growth at 7.3% CAGR during the forecast period. Hearing implant market valuation will surpass...

Sensorion Announces Approval in Australia to Initiate Proof of Concept Clinical Trial of SENS-401 for Residual Hearing Preservation During Cochlear Implantation - Vimarsana News

Sensorion Announces Approval in Australia to Initiate Proof of Concept Clinical Trial of SENS-401 for Residual Hearing Preservation During Cochlear Implantation

Australian approval follows recent trial approval by regulatory authorities in France Regulatory News: Sensorion (FR0012596468 ALSEN), a pioneering clinical-stage biotechnology company which

Sensorion Announces Approval in Australia to Initiate Proof of Concept Clinical Trial of SENS-401 fo - Vimarsana News

Sensorion Announces Approval in Australia to Initiate Proof of Concept Clinical Trial of SENS-401 fo

Australian approval follows recent trial approval by regulatory authorities in FranceMONTPELLIER, France--(BUSINESS WIRE)--Regulatory News:Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within t...